HQH
Tekla Healthcare Investors
19.90$
+4.2%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
Tekla Healthcare Investors (HQH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q3 25), "Revenue" came in at 17 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q3 25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.6 | 1.4 | 2.7 | 1.2 | 2.3 | 1.2 | 2.5 | 1.4 | 2.8 | 1.4 | 2.8 | 3.0 | 3.0 | 3.8 | 3.8 | 3.7 | 3.7 | 1.9 | 3.9 | 2.5 | 5.0 | 2.0 | 3.9 | 1.6 | 3.3 | 1.6 | 3.2 | 2.0 | 4.0 | 56 | 4.3 | 25 | 5.6 | 75 | 4.7 | 2.7 | 5.3 | 5.5 | 5.5 | 17 | |
| – | 6.0 | – | 5.3 | – | 4.9 | – | 4.7 | 4.7 | 5.1 | 5.1 | 5.0 | 5.0 | 5.0 | 5.0 | 4.9 | 4.9 | 4.8 | 4.8 | 4.8 | – | 5.2 | – | 5.7 | – | 6.1 | – | 5.7 | – | 5.4 | – | 5.5 | – | 5.4 | – | 5.2 | – | – | – | 5.1 | |
| 1.6 | 1.4 | 2.7 | 1.2 | 2.3 | 1.2 | 2.5 | 1.4 | 2.8 | 1.4 | 2.8 | -2.0 | 3.0 | -1.2 | 3.8 | -1.2 | 3.7 | 1.9 | 3.9 | 2.5 | 5.0 | 2.0 | 3.9 | 1.6 | 3.3 | 1.6 | 3.2 | 2.0 | 4.0 | 51 | 4.3 | 20 | 5.6 | 70 | 4.7 | 2.7 | 5.3 | 5.5 | 5.5 | 12 | |
| – | 0.0 | – | – | – | 0.0 | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 5.7 | 3.2 | 6.4 | 2.9 | 5.8 | 2.6 | 5.3 | 2.6 | 5.2 | 2.8 | 5.6 | 0.3 | 5.4 | 0.3 | 5.5 | 0.3 | 5.3 | 2.6 | 5.2 | 2.6 | 5.2 | 2.8 | 5.7 | 3.1 | 6.2 | 3.3 | 6.6 | 3.1 | 6.2 | 2.9 | 5.7 | 2.9 | 5.8 | 2.8 | 5.7 | 2.7 | 5.3 | 5.6 | 5.6 | – | |
| 5.7 | 56 | 6.4 | 60 | 5.8 | 30 | 5.3 | 16 | 5.2 | 41 | 5.6 | 0.5 | 5.4 | 0.4 | 5.5 | 0.4 | 5.3 | 32 | 5.2 | 22 | 5.2 | 95 | 5.7 | 43 | 6.2 | 32 | 6.6 | 60 | 6.2 | 42 | 5.7 | 39 | 5.8 | 16 | 5.7 | 2.7 | 5.3 | 5.7 | 5.7 | -162 | |
| -4.1 | -3.7 | -3.7 | -3.5 | -3.5 | -2.8 | -2.8 | -2.4 | -2.4 | -2.8 | -2.8 | -2.5 | -2.5 | -1.7 | -1.7 | -1.6 | -1.6 | -1.3 | -1.3 | -0.2 | -0.2 | -0.9 | -1.8 | -1.4 | -2.9 | -1.7 | -3.3 | -58 | -2.2 | -79 | -1.4 | 83 | -0.2 | -27 | -1.0 | 100 | 0.0 | -0.2 | -0.2 | 173 | |
| – | 105 | – | 115 | – | 65 | – | 38 | 0.0 | 88 | 0.0 | 63 | 0.0 | 136 | – | 83 | – | 60 | – | 48 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 205 | -54 | -109 | -59 | -119 | 31 | 62 | 18 | 36 | 43 | 86 | -66 | -66 | 135 | 135 | -84 | -84 | -30 | -61 | 24 | 48 | 97 | 193 | 44 | 89 | 33 | 67 | -58 | -115 | -79 | -79 | 83 | 83 | -27 | -27 | 50 | 100 | 85 | 85 | 173 | |
| -53 | 0.0 | -58 | – | 33 | 0.0 | 19 | – | 44 | 0.0 | -32 | 0.0 | 68 | 0.0 | -41 | – | -30 | – | 24 | – | 97 | 97 | 46 | 46 | 35 | 35 | -56 | -56 | -39 | 0.0 | 42 | 0.0 | -13 | 0.0 | 50 | 0.0 | – | – | – | – | |
| 205 | -54 | -109 | -59 | -119 | 31 | 62 | 18 | 36 | 43 | 86 | -66 | -66 | 135 | 135 | -84 | -84 | -30 | -61 | 24 | 48 | 97 | 193 | 44 | 89 | 33 | 67 | -58 | -115 | -79 | -79 | 83 | 83 | -27 | -27 | 50 | 100 | 85 | 85 | 173 | |
| -53 | -53 | -58 | -58 | 33 | 33 | 19 | 19 | 44 | 44 | -32 | -66 | 68 | 271 | -41 | -84 | -30 | -30 | 24 | 24 | 97 | 97 | 46 | 46 | 35 | 35 | -56 | -56 | -39 | -79 | 42 | 83 | -13 | -27 | 50 | 100 | – | – | – | 173 |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.